EBPS Immunopsychiatry Workshop

Matthew Taylor

Matthew Taylor

Effects Of Interferon-Alpha Treatment On Cortical Glutamatergic Function

Matthew Taylor

Institute of Psychiatry, King's College London

My research interests lie in the causes and treatment of bipolar disorder particularly in its earliest stages. I work clinically within Early Intervention - people with bipolar disorder typically have the illness for ten years before receiving the correct diagnosis; reducing this diagnostic delay through early detection and early intervention has the potential to truly transform outcomes.

My clinical work informs my interests across a range of related areas:

  • understanding vulnerability and resilience mechanisms, and the possibility of diagnostic markers, through techniques such as Magnetic Resonance Spectroscopy
  • developing the best available evidence to inform treatment choices, particularly through advanced meta-analysis of clinical trial data
  • using the Clinical Record Interactive Search (CRIS) System to better understand the realities of care for bipolar disorder
  • evaluating promising new interventions for improved wellbeing and long term outcomes